Are plasma soluble endoglin levels an indicator of cardiovascular alterations in hypertensive and diabetic patients?
Plasma soluble endoglin levels may serve as a biomarker for endothelial dysfunction and cardiovascular damage in patients with hypertension and diabetes.
This study shows that endoglin is an indicator of hypertension- and diabetes-associated vascular pathologies as endothelial dysfunction and cardiovascular damage.
Blázquez‐Medela et al. (Wed,) studied this question.